Royalty Pharma plc announced an expansion of its leadership team. Art McGivern has joined Royalty Pharma as Executive Vice President, Investments & General Counsel and George Lloyd has been promoted to Executive Vice President, Investments & Chief Legal Officer. Art McGivern joins Royalty Pharma from Goodwin Procter where he was a partner in its Life Sciences Group.

He has been Royalty Pharma's lead outside lawyer on substantially all investment transactions since 2012. Art brings experience across public and private securities offerings, mergers and acquisitions, royalty-based financings and other complex transactions, and has advised companies in their ongoing corporate matters. Art has a BSCE from Tufts University and a JD from Boston University.George Lloyd leads the legal and compliance functions at Royalty Pharma.

He joined Royalty Pharma in 2011 after representing Royalty Pharma on all transactional work since 2006. George was previously a partner in Goodwin Procter'sPrivate Equity Group. He has an AB from Princeton University and a JD from New York University Law School.